Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC 12:0_22:6)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003409 AN005596 Impact of giredestrant on the lipid profile of MCF-7 breast cancer cells Cultured cells Human Cancer Genentech Inc. LC-MS
ST002522 AN004156 Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice Liver Mouse Oxidative stress University of Science and Technology of China LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
  logo